Log In
Print
BCIQ
Print
Print this Print this
 

Emapticap pegol (NOX-E36)

  Manage Alerts
Collapse Summary General Information
Company Noxxon Pharma AG
DescriptionL-aptamer monocyte chemoattractant protein-1 (MCP-1; CCL2) inhibitor developed using Spiegelmer technology
Molecular Target Monocyte chemoattractant protein-1 (MCP-1) (CCL2)
Mechanism of ActionMonocyte chemoattractant protein-1 (MCP-1) (CCL2) inhibitor
Therapeutic ModalityNucleic acid: Aptamer

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today